Clinical Trials Browser

Completed × Interventional × 3-Iodobenzylguanidine × Clear all

NCT01175356 2026-01-23

Induction Therapy Including 131 I-MIBG and Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma Undergoing Stem Cell Transplant, Radiation Therapy, and Maintenance Therapy With Isotretinoin

Phase 1 Completed

99 enrolled 11 charts

Neuroblastoma, Ganglioneuroblastoma

NCT01850888 2025-12-18

MIBG for Refractory Neuroblastoma and Pheochromocytoma

Phase NA Completed

Neuroblastoma, Pheochromocytoma

NCT03332667 2025-04-16

MIBG With Dinutuximab +/- Vorinostat

Phase 1 Completed

45 enrolled 16 charts

Neuroblastoma

NCT04510311 2025-01-10

Imaging Properties of PET Radiotracer [18F]3F-PHPG in Patients With Neuroendocrine Tumors

Phase EARLY_PHASE1 Completed

Neuroendocrine Tumors

NCT00253435 2023-04-10

N2001-02: I-MIBG With Intensive Chemotherapy and Autologous Stem Cell Rescue for High-Risk Neuroblastoma

Phase 2 Completed

50 enrolled 12 charts

Neuroblastoma

NCT01019850 2023-04-10

N2007-03: Vorinostat and 131-I MIBG in Treating Patients With Resistant or Relapsed Neuroblastoma

Phase 1 Completed

Neuroblastoma

NCT02035137 2022-06-08

N2011-01

Phase 2 Completed

114 enrolled 13 charts

Neuroblastoma

NCT00126412 2019-05-31

Meta-Iodobenzylguanidine (123I mIBG) Scintigraphy in Patients Being Evaluated for Phaeochromocytoma or Neuroblastoma

Phase 3 Completed

Disease, Neuroblastoma, Pheochromocytoma

NCT01313936 2019-04-29

High-Dose 131I-MIBG Therapy Combined With Vincristine and Five Days of Irinotecan for Resistant/Relapsed Neuroblastoma

Phase 1 Completed

32 enrolled 8 charts

Neoplasms, Neuroblastoma, Recurrence

NCT00037869 2018-10-31

High Dose I-131 Metaiodobenzylguanidine(MIBG) for Metastatic Neuroendocrine Tumors

Phase 3 Completed

Neoplasm Metastasis, Neuroendocrine Tumors

NCT01413503 2018-09-18

A Phase II Study of 131I- Metaiodobenzylguanidine (MIBG) for Treatment of Metastatic or Unresectable Pheochromocytoma and Related Tumors

Phase 2 Completed

50 enrolled 7 charts

Neoplasms, Paraganglioma, Pheochromocytoma, Recurrence

NCT00960739 2016-08-08

MIITOP

Phase 2 Completed

Neuroblastoma

NCT01099228 2016-07-21

Combination Targeted Radiotherapy in Neuroendocrine Tumors

Phase NA Completed

Neuroendocrine Tumors

NCT00458952 2016-07-13

Phase 1 Study of Iobenguane (MIBG) I 131 in Patients With Malignant Pheochromocytoma/Paraganglioma

Phase 1/2 Completed

24 enrolled 8 charts

CNSEndocrineNET

Paraganglioma, Pheochromocytoma, Neuroendocrine Tumors

NCT00293319 2014-08-18

131 I-MIBG in Treating Patients With Refractory or Relapsed Neuroblastoma

Phase 2 Completed

Neuroblastoma

NCT00005978 2010-10-15

N99-01: Combination Chemotherapy, Radiation Therapy, and Stem Cell Transplantation in Treating Patients With Neuroblastoma

Phase 1 Completed

Neuroblastoma

NCT00083135 2010-10-15

N2000-01: Double Infusion of Iodine I 131 Metaiodobenzylguanidine Followed by Autologous Stem Cell Transplantation

Phase 1 Completed

Neuroblastoma